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A B S T R A C T
The coexistence of chronic lymphocytic (CLL) and chronic myeloid leukemia (CML) in the same patient has only been
reported occasionally. Most of these cases represent the patients who developed CLL during the course of CML. Re-
viewing the literature, only a few cases of simultaneous occurrence of CLL and CML were found. Here we represent a pre-
viously healthy 50-year old man in whom the diagnosis of CLL and CML was established by FNAB of the bone marrow.
The diagnosis was then confirmed by histopathology, immunophenotypization of the peripheral blood and by a cyto-
genetic study of the bone marrow. Four years after the diagnosis the patient is well, with leucocytosis of 40109/L, and
lymphocytosis of 93%.
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Introduction
The coexistence of chronic lymphocytic leukemia
(CLL) and chronic myeloid leukemia (CML) in the same
patient is very rare. Most of these cases represent the pa-
tients who developed chronic lymphoid leukemia (CLL)
during the course of chronic myeloid leukemia (CML), so
the leukemogenic effect of the therapy claimed as a possi-
ble risk factor for second malignancy1–13. The impaired
immune response associated with CLL could also con-
tribute to the increased risk of second neoplasia, but CLL
patients mostly develop non-Hodgkin lymphoma and so-
lid tumors and rarely acute myeloid leukemia, myelo-
dysplastic syndromes and CML14. Reviewing the litera-
ture, only a few cases of CLL and CML were found1,5,6,8,9.
Here we represent a patient with a simultaneous occur-
rence of CLL and CML. The diagnosis was established by
FNA of the bone marrow and was confirmed by histopa-
thology, immunophenotypization of the peripheral blood
and by a cytogenetic study of the bone marrow.
Case Report
A previously healthy 50-year old man was refered to
our clinic after the discovery of leukocytosis and throm-
bocytosis. Physical examination was normal, without
any lymphadenopathy or hepatosplenomegaly. The he-
moglobin (Hb) was 166g/L, white blood cell count (WBC)
17109/L (neutrophils 49%, eosinophils 2%, basophils
1%, lymphocytes 45% and monocytes 3%, with numerous
»smudge cells«), and platelet count (Plt) 720109/L. The
serum lactat dehydrogenase (LDH) level was 198 U/L
(norm. 114–241 U/L). The bone marrow aspirate was
hypercellular, with abundant thrombopoiesis, a few mi-
cromegakariocytes, and platelets in clusters. There were
also a slightly increased number of mature eosynophilic
forms (Figure 1). The number of lymphocytes was in-
creased (28–33% of all cells) (Figure 2). The cytological
diagnosis was myelo- and lymphoproliferative disease.
The bone marrow biopsy was performed, and revealed as
well a hypercellular bone marrow aspirate with an in-
creased number of eosinophils and large, hyperlobulated
megakariocytes. Some small lymphoid nodules and inter-
stitial accumulation of lymphocytes were also found, so
the diagnosis was chronic lymphocytic and chronic mye-
loid leukemia. The cytogenetic study of the bone marrow
made by FISH showed the Ph chromosome, and PCR of
the bone marrow revealed the clonal rearrangement of
gene for immunoglobulin heavy chain (IgH). Immuno-
phenotypization of peripheral blood lymphocytes demon-
strated the expression of mature B-cell markers (CD19,
CD20, CD23) and also CD5 positive cells. A year after the
653
Received for publication September 17, 2009
diagnosis the WBC was 24109/L and Plt were 1007109/L,
so hydroxyurea was introduced in the therapy and six
months later also was imatinib mesylate. After 6 months
of the imatinib mesylate therapy, control cytogenetic
FISH and molecular RT-PCR analyses were done and Ph
chromosome and bcr/abl transcript were negative. Four
years after the diagnosis, the patient is well, without
lymphadenopathy and splenomegaly. The WBC is 40109/L
and lymphocytosis is 93%. Interesting is, that a year af-
ter the diagnosis, the patient’s father also developed
CLL.
Discussion
Sequential and simultaneous occurrence of CLL and
CML has been reported only occasionally. The coexi-
stence of these two hematologic malignancies leads to
some questions about their cell of origin. The CML and
CLL association might be explained that both diseases
originate from a unique stem cell capable of differentiat-
ing into two different cell lines. However, some stu-
die’s6,7,8,15 results demonstrated independent bi-clonal
evolution of these two diseases and a different origin of
CLL and CML leukemic cells. Zollino et al.7 analyzed, in
a patient with CML following CLL, the expression of mo-
lecular markers specific for CLL and CML proliferation,
(bcr/abl rearrangement for CML and J segment of heavy
chain immunoglobulin (JH) for CLL). They detected
bcr/abl rearrangement in the granulocytic, but not in the
mononuclear cell fraction, probably composed mainly of
CLL cells. On the contrary, they observed by JH rear-
rangement analysis a characteristic JH band correspond-
ing to a monoclonal lymphoid population in the lym-
phoid-enriched but not in the myeloid blood fraction.
There is also a case16 of a patient who developed CLL
some years after the diagnosis of CML with a molecular
data documenting a separate clonal origin. In the re-
ported patient a population of clonal CD19+ B cells was
detected, without an expression of bcr/abl, and bcr/abl
positive CML clone was also found in the granulocyte
and mononuclear cell fractions. The documentated data
indicate that CLL leukemic cells developed from other
different cell than a CML pluripotent progenitor cell.
One of the bcr/abl negative mature B cell clone was
transformed resulting in clonal lymphoid proliferation
and a subsequent development of CLL. Esteve et al.17
showed a patient with a coexistent CML and early stage
CLL, who further developed B-lineage lymphoid blast
crisis. The analysis of JH rearrangement pattern of se-
quential samples supports the origin of the diseases in
two different cell clones. Moreover, »our patient’s« father
developed CLL, implicating that the two malignant dis-
eases, as well as the familial occurrence of the same dis-
ease, may be associated with genetic factors. Thus, Ca-
pablo S. et al.18 also found a high prevalence of CLL in
the relatives of CLL patients.
In conclusion, the report of our patient with a simul-
taneous occurrence of CML and CLL contribute to other
similar reports pointing to an increased risk for the sec-
ondary hematological malignancy in patients with the di-
agnosis of a hematoproliferative disease and many possi-
ble risk factors (cytostatic therapy, impaired immune
response, genetic factors, etc) that may be involved in its
occurrence. Immunophenotypic, cytogenetic and molecu-
lar analysis in most patients with the simultaneous or
the subsequential CML and CLL revealed a rare event of
hematologic leukemogenesis caused by the independent
bi-clonal evolution. Our report points also to the impor-
tance of FNA diagnostics because the diagnosis of a
simulteneous appearance of two hematological diseases
was established by FNA of the bone marrow and con-
firmed afterwards by histopathology, cytogenetic and
immunophenotypization of the bone marrow and periph-
eral blood.
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Fig. 1. Increased number of eosinophylic forms in the bone
marrow aspirate, May-Grünwald-Giemsa stain, 1000.
Fig. 2. Increased number of lymphocytes in the bone marrow
aspirate, May-Grünwald-Giemsa stain, 1000.
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SIMULTANA POJAVA KRONI^NE LIMFATI^NE I KRONI^NE MIJELOI^NE LEUKEMIJE
U ISTOG PACIJENTA
S A @ E T A K
Postojanje kroni~ne limfati~ne (CLL) i kroni~ne mijeloi~ne leukemije (CML) u istog pacijenta vrlo je rijetka pojava.
U ve}ine bolesnika s te dvije hematolo{ke bolesti, CLL se javlja nakon dijagnoze CML-a. U literaturi je opisano nekoliko
bolesnika u kojih je dijagnosticirana CLL i CML i tek nekoliko s istovremenom pojavom obje navedene bolesti. U ovom
je radu prikazan 50-godi{nji pacijent koji je prethodno bio zdrav i u kojeg je dijagnoza CLL i CML postavljena citolo-
{kom punkcijom ko{tane sr`i, a potvr|ena biopsijom i citogenetskom analizom ko{tane sr`i i imunonfenotipizacijom
limfocita periferne krvi. ^etiri godine nakon postavljanja dijagnoze, pacijent je dobro s leukocitozom 40109/L i lim-
focitozom od 93% u diferencijalnoj krvnoj slici.
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